Polyomavirus middle-T antigen lacking a membrane anchor sequence accumulates in the nucleus

Area of Science:

• Virology
• Molecular Biology
• Oncology

Background:

• Polyomavirus replication involves early-expressed proteins essential for tumorigenesis.
• Middle-T antigen, a key viral protein, interacts with cellular signaling proteins like c-Src and phosphatase 2A.
• Membrane association of middle-T antigen is critical for its cell transformation capabilities.

Purpose of the Study:

• To investigate the role of middle-T antigen's membrane association and phosphatase 2A binding in polyomavirus-mediated tumorigenesis.
• To determine the mechanisms underlying the nuclear localization of middle-T antigen and its functional consequences.

Main Methods:

• Construction and analysis of a mutant polyomavirus encoding a truncated middle-T antigen lacking membrane-associating sequences.
• Examination of middle-T antigen's binding interactions with cellular proteins, specifically phosphatase 2A.
• Investigation of middle-T antigen's subcellular localization (nucleus vs. cytoplasm) using mutated forms.

Main Results:

• A mutant middle-T antigen lacking membrane association was non-oncogenic.
• Truncated middle-T antigen retained binding to phosphatase 2A and localized to the nucleus despite lacking a classical nuclear targeting sequence.
• Mutations disrupting middle-T antigen's binding to phosphatase 2A resulted in cytoplasmic localization and prevented nuclear accumulation.

Conclusions:

• Middle-T antigen's oncogenic potential is linked to its membrane association and interaction with cellular signaling pathways.
• Nuclear localization of truncated middle-T antigen appears to be mediated by its interaction with phosphatase 2A.
• Understanding these interactions provides insights into polyomavirus oncogenesis and potential therapeutic targets.